Headache News and Research

Latest Headache News and Research

mAb treatment can rapidly select for SARS-CoV-2 resistance, suggests study

A study evaluates the efficacy of a mAb to prevent disease progression in non-hospitalized persons with symptomatic SARS-CoV-2 infection.

17 Sep 2021

Review: Long COVID symptoms rarely persisted beyond 12 weeks in young people

Long COVID symptoms rarely persisted beyond 12 weeks in children and adolescents, unlike adults. But more studies were required to investigate the risk and impact of long COVID in young people to help guide vaccine policy decisions in Australia, according to a review led by the Murdoch Children's Research Institute (MCRI).

17 Sep 2021

Researchers examine the persistent effects of COVID-19 on vascular function of young adults

In a first-of-its-kind study, researchers have examined the persistent effects of SARS-CoV-2 infection on the vascular function of otherwise healthy young adults. The research, published in the American Journal of Physiology-Heart and Circulatory Physiology, was chosen as an APSselect article for September.

16 Sep 2021

Pediatric SARS-CoV-2 infections usually mild, says study

A new study in the journal BMC Pediatrics describes the clinical phenotypes and outcomes in a thousand children who developed COVID-19.

16 Sep 2021

When covid deaths are dismissed or stigmatized, grief is mixed with shame and anger

Months after Kyle Dixon died, his old house in Lanse, Pennsylvania, is full of reminders of a life cut short.

16 Sep 2021

IL-1-Ra autoantibodies observed in high frequency in children with PIMS/MIS-C

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection typically affects children only mildly, multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS) is a serious but rare complication occurring after infection.

16 Sep 2021

School children in Switzerland show willingness to mask-wearing

A school-based survey has revealed that about 60% of students in Zurich perceive mask-wearing at school as a useful intervention for controlling SARS-CoV-2 transmission.

10 Sep 2021

German study finds lack of association between SARS-CoV-2 infection and neuroaxonal damage

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the virus that causes coronavirus disease 2019 (COVID-19) – is not associated with neuroaxonal damage, according to a new study from researchers in Germany.

8 Sep 2021

Seizures as a main manifestation of severe pediatric SARS-CoV-2 infection

A new study aimed to investigate the clinical, demographic, laboratory, neurophysiological, and imaging characteristics of children admitted to the ED with seizures and acute SARS-CoV-2 infection.

8 Sep 2021

V-safe: How everyday people help the CDC track covid vaccine safety with their phones

Of the 203 million people who have received at least one dose of a covid-19 vaccine, more than 9 million have enrolled in a program to share information about their health since getting the shot.

7 Sep 2021

The pandemic almost killed Allie. Her community’s vaccination rate is 45%.

The Allie Henderson who stepped out of her mother's car to a driveway full of cheering friends and family holding "Welcome Home" signs was a wisp of her former self.

7 Sep 2021

Study sheds light on neurologic symptoms caused by SARS-CoV-2 infection

Researchers in Australia and Finland have provided important insights into how infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – might affect nervous system circuitries and cause neurologic symptoms.

6 Sep 2021

Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant

A new variant (lineage C.37) initially identified in Lima, Peru, has since been classified as “Lambda” by the World Health Organization (WHO). The lambda variant was classified in June 2021 by the WHO as a “variant of interest.”

6 Sep 2021

Smell abnormalities more common among long-COVID Patients

A new study investigates the rising prevalence of abnormalities in the sense of smell persisting in COVID-19 patients.

3 Sep 2021

Your covid game plan: Are stadiums safe?

The college football season is kicking into high gear, the National Football League season starts Sept. 9, and the baseball pennant races are heating up. For the first time since 2019, nearly all stadiums will be fully open to fans.

3 Sep 2021

Regional differences in prevalence of SARS-CoV-2 antibodies in children

A population-based study assesses seroprevalence in a representative sample of children from regions with high and low community transmission.

2 Sep 2021

COVID-19 associated mucormycosis cases in India

India continues to grapple with the coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, the country has reported over one million new cases for the past 28 days.

31 Aug 2021

Researchers identify 55 lingering effects of COVID-19

As COVID-19 hospitalizations once again soar in a fourth surge more than 18 months after the pandemic started, some patients continue to experience symptoms long after recovering from COVID, according to a Houston Methodist study recently published in Nature's Scientific Reports.

30 Aug 2021

Have SARS-CoV-2 symptoms changed in the UK population over time?

A new paper compares changes in the symptoms due to COVID-19 over the course of the pandemic.

29 Aug 2021

Pfizer COVID-19 jab side effects likely to be mild to moderate in extremely vulnerable 12-15 year olds

The side effects of the Pfizer-BioNTech jab against COVID-19 are likely to be mild to moderate and clear up quickly in 12-15 year olds at high risk of complications from the infection because of certain coexisting conditions, reveals a small study accepted for publication in the Archives of Disease in Childhood.

28 Aug 2021